The DOI matches its Crossref record; 143 of the 145 references it cites were found in a registry or an index.
Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline
Open accessAbstract
OBJECTIVE: Our objective was to develop clinical practice guidelines for the diagnosis and treatment of patients with primary aldosteronism. PARTICIPANTS: The Task Force comprised a chair, selected by the Clinical Guidelines Subcommittee (CGS) of The Endocrine Society, six additional experts, one methodologist, and a medical writer. The Task Force received no corporate funding or remuneration. EVIDENCE: Systematic reviews of available evidence were used to formulate the key treatment and prevention recommendations. We used the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) group criteria to describe both the quality of evidence and the strength of recommendations. We used "recommend" for strong recommendations and "suggest" for weak recommendations. CONSENSUS PROCESS: Consensus was guided by systematic reviews of evidence and discussions during one group meeting, several conference calls, and multiple e-mail communications. The drafts prepared by the task force with the help of a medical writer were reviewed successively by The Endocrine Society's CGS, Clinical Affairs Core Committee (CACC), and Council. The version approved by the CGS and CACC was placed on The Endocrine Society's Web site for comments by members. At each stage of review, the Task Force received written comments and incorporated needed changes. CONCLUSIONS: We recommend case detection of primary aldosteronism be sought in higher risk groups of hypertensive patients and those with hypokalemia by determining the aldosterone-renin ratio under standard conditions and that the condition be confirmed/excluded by one of four commonly used confirmatory tests. We recommend that all patients with primary aldosteronism undergo adrenal computed tomography as the initial study in subtype testing and to exclude adrenocortical carcinoma. We recommend the presence of a unilateral form of primary aldosteronism should be established/excluded by bilateral adrenal venous sampling by an experienced radiologist and, where present, optimally treated by laparoscopic adrenalectomy. We recommend that patients with bilateral adrenal hyperplasia, or those unsuitable for surgery, optimally be treated medically by mineralocorticoid receptor antagonists.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mineralocorticoid excess can be caused by either bilateral hyperplasia or ACA, and these lesions are usually small (<2 cm) (115).”
From Adrenocortical carcinoma (2014) · cites this paper as [115]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J., & Gatlin, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030207 · Cited by 4,941
Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism
Milliez, P., Girerd, X. J., Plouin, P., Blacher, J., Safar, M. E., & Mourad, J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.015 · Cited by 1,541
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients
Rossi, G. P., Bernini, G., Caliumi, C., Desideri, G., Fabris, B., Ferri, C., Ganzaroli, C., Giacchetti, G., Letizia, C., Maccario, M., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.059 · Cited by 1,467
Self-citationLifton, R. P., Dluhy, R. G., Powers, M., Rich, G. M., Cook, S., Ulick, S., & Lalouel, J.-M. (1992) · Nature · doi:10.1038/355262a0 · Cited by 1,158
The Incidentally Discovered Adrenal Mass
Young, W. F. (2007) · New England Journal of Medicine · doi:10.1056/nejmcp065470 · Cited by 1,090
Self-citationMulatero (2004) · doi:10.1210/jc.2003-031337 · Cited by 961
Self-citationA Survey on Adrenal Incidentaloma in Italy
Mantero, F. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.2.637 · Cited by 907
Self-citationIncidentally Discovered Adrenal Masses*
Kloos, R. T., Gross, M. D., Francis, I. R., KOROBKIN, M. T., & Shapiro, B. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-4-460 · Cited by 869
Hyperaldosteronism Among Black and White Subjects With Resistant Hypertension
Calhoun, D. A., Nishizaka, M. K., Zaman, M. A., Thakkar, R. B., & Weissmann, P. (2002) · Hypertension · doi:10.1161/01.hyp.0000040261.30455.b6 · Cited by 763
Flagged first, then by citations
2 of the 145 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Ganguly, 1976, Spironolactone therapy in primary aldosteronism: diagnostic and therapeutic implications, In: Sambhi MP, ed. Systemic effects of antihypertensive agents. New York: Stratton;, 383
Cited by
Sorted by citations
Items 401–500 of 1,000
Renin and Aldosterone Measurements in the Management of Arterial Hypertension
Viola, A., Monticone, S., Burrello, J., Buffolo, F., Lucchiari, M., Rabbia, F., Williams, T. A., Veglio, F., Mengozzi, G., & Mulatero, P. (2015) · Hormone and Metabolic Research · doi:10.1055/s-0035-1548868 · Cited by 36
Clinical Characteristics and Follow-Up Results of Adrenal Incidentaloma
Yılmaz, N., Avşar, E., Tazegül, G., Sarı, R., Altunbaş, H., & Balcı, M. K. (2020) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1079-4915 · Cited by 38
Hypertensive Crisis in Pediatric Patients: An Overview
Raina, R., Mahajan, Z., Sharma, A., Chakraborty, R., Mahajan, S., Sethi, S. K., Kapur, G., & Kaelber, D. C. (2020) · Frontiers in Pediatrics · doi:10.3389/fped.2020.588911 · Cited by 39
Adrenal vein sampling: Substantial need for technical improvement at regional referral centres
Elliott, P., & Holmes, D. T. (2013) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2013.04.004 · Cited by 36
Solař, M., Malířová, E., Ballon, M., Pelouch, R., & Ceral, J. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-0914 · Cited by 36
Characteristics of Japanese aldosterone-producing adenomas with KCNJ5 mutations
Okamura, T., Nakajima, Y., Katano-Toki, A., Horiguchi, K., Matsumoto, S., Yoshino, S., Yamada, E., Tomaru, T., Ishii, S., Saito, T., et al. (2016) · Endocrine Journal · doi:10.1507/endocrj.ej16-0243 · Cited by 36
Chiang, W., Cheng, C.-J., Wu, S., Sun, G., Lin, M., Sung, C., & Lin, S. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.05.017 · Cited by 35
Mailhot, J., Traistaru, M., Soulez, G., Ladouceur, M., Giroux, M.-F., Gilbert, P., Zhu, P. S., Bourdeau, I., Oliva, V. L., Lacroix, A., et al. (2015) · Radiology · doi:10.1148/radiol.2015142413 · Cited by 35
Yang, Y., Zhu, L., Xu, J., Tang, X., & Gao, P. (2016) · Hypertension Research · doi:10.1038/hr.2016.127 · Cited by 35
MicroRNA-21 ablation exacerbates aldosterone-mediated cardiac injury, remodeling, and dysfunction
Syed, M., Ball, J. P., Mathis, K. W., Hall, M. E., Ryan, M. J., Rothenberg, M. E., Cardozo, L. L. Y., & Romero, D. G. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00155.2018 · Cited by 35
Wolley, M. J., Gordon, R. D., Pimenta, E., Daunt, N., Slater, G. J., Ahmed, A. H., & Stowasser, M. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e328362add3 · Cited by 35
Self-citationCarter, S., Owen, L. J., Kerstens, M. N., Dullaart, R. P. F., & Keevil, B. G. (2012) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2012.011186 · Cited by 35
The subtyping of primary aldosteronism by adrenal vein sampling
Rossitto, G., Battistel, M., Barbiero, G., Bisogni, V., Maiolino, G., D, D. M. M., Seccia, T. M., & Rossi, G. P. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001564 · Cited by 35
Interventional radiology of the adrenal glands: current status
Ierardi, A. M., Petrillo, M., Patella, F., Biondetti, P., Fumarola, E. M., Angileri, S. A., Pesapane, F., Pinto, A., Dionigi, G., & Carrafiello, G. (2018) · Gland Surgery · doi:10.21037/gs.2018.01.04 · Cited by 35
Treatment of Primary Aldosteronism and Organ Protection
Catena, C., Colussi, G., & Sechi, L. A. (2015) · International Journal of Endocrinology · doi:10.1155/2015/597247 · Cited by 34
The management of aldosterone-producing adrenal adenomas—does adrenalectomy increase costs?
Reimel, B., Zanocco, K. A., Russo, M. J., Zarnegar, R., Clark, O. H., Allendorf, J., Chabot, J. A., Duh, Q., Lee, J. A., & Sturgeon, C. (2010) · Surgery · doi:10.1016/j.surg.2010.09.012 · Cited by 34
Genetics in endocrinology: Genetics of mineralocorticoid excess: an update for clinicians
Zennaro, M., Rickard, A. J., & Boulkroun, S. (2013) · European Journal of Endocrinology · doi:10.1530/eje-12-0813 · Cited by 34
Advances in Bioanalytical Techniques to Measure Steroid Hormones in Serum
French, D. (2016) · Bioanalysis · doi:10.4155/bio-2015-0025 · Cited by 34
Genetics of primary hyperaldosteronism
Dutta, R. K., Söderkvist, P., & Gimm, O. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0055 · Cited by 36
Targeted Molecular Imaging in Adrenal Disease—An Emerging Role for Metomidate PET-CT
Mendichovszky, I. A., Powlson, A., Manavaki, R., Aigbirhio, F. I., Cheow, H., Buscombe, J. R., Gurnell, M., & Gilbert, F. J. (2016) · Diagnostics · doi:10.3390/diagnostics6040042 · Cited by 34
Liu, P., Zhang, S., Gao, J., Lin, Y., Shi, G., He, W., Touyz, R. M., Yan, L., & Huang, H. (2018) · Hypertension · doi:10.1161/hypertensionaha.117.10644 · Cited by 34
Yin, G., Zhang, S., Yan, L., Wu, M., Xu, M., Li, F., & Cheng, H. (2012) · Endocrine · doi:10.1007/s12020-012-9609-z · Cited by 34
Vascular Disturbances in Primary Aldosteronism: Clinical Evidence
Widimsky, J., Jr., Štrauch, B., Petrák, O., Rosa, J., Šomlóová, Z., Zelinka, T., & Holaj, R. (2012) · Kidney & Blood Pressure Research · doi:10.1159/000340031 · Cited by 34
A Consideration of Genetic Mechanisms Behind the Development of Hypertension in Blacks
Tu, W., & Pratt, J. H. (2013) · Current Hypertension Reports · doi:10.1007/s11906-013-0332-9 · Cited by 34
Prejbisz, A., Florczak, E., Klisiewicz, A., Dobrowolski, P., Janaszek-Sitkowska, H., Bieleń, P., Szwench-Pietrasz, E., Warchoł-Celińska, E., Kołodziejczyk-Kruk, S., Janas, J., et al. (2013) · Endokrynologia Polska · doi:10.5603/ep.2013.0019 · Cited by 33
Gómez-Sánchez, C. E., & Oki, K. (2013) · Endocrinology · doi:10.1210/en.2013-1733 · Cited by 33
Nakajima, Y., Okamura, T., Gohko, T., Satoh, T., Hashimoto, K., Shibusawa, N., Ozawa, A., Ishii, S., Tomaru, T., Horiguchi, K., et al. (2014) · Endocrine Journal · doi:10.1507/endocrj.ej14-0282 · Cited by 32
The use of mass spectrometry to improve the diagnosis and the management of the HPA axis
Monaghan, P. J., Keevil, B. G., & Trainer, P. J. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-013-9240-1 · Cited by 32
Rossi, G. P., Maiolino, G., & Seccia, T. M. (2019) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2019.08.012 · Cited by 35
Castro, M. A., Valderrábano, P., Escobar-Morreale, H. F., Hanzu, F. A., & Casals, G. (2020) · Endocrine · doi:10.1007/s12020-020-02544-6 · Cited by 34
The Effect of Antihypertensive Medications on Testing for Primary Aldosteronism
Jędrusik, P., Symonides, B., Lewandowski, J., & Gaciong, Z. A. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.684111 · Cited by 33
Progesterone increase counteracts aldosterone action in a pregnant woman with primary aldosteronism
Ronconi, V., Turchi, F., Zennaro, M., Boscaro, M., & Giacchetti, G. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03901.x · Cited by 33
Salt, aldosterone and hypertension
Pimenta, E., Gordon, R. D., & Stowasser, M. (2012) · Journal of Human Hypertension · doi:10.1038/jhh.2012.27 · Cited by 33
Self-citationTreatment of primary aldosteronism
Quinkler, M. O., & Stewart, P. M. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.10.001 · Cited by 35
Kawasaki, Y., Ishidoya, S., Kaiho, Y., Ito, A., Satoh, F., Morimoto, R., Nakagawa, H., & Arai, Y. (2011) · International Journal of Urology · doi:10.1111/j.1442-2042.2011.02846.x · Cited by 32
Emdin, M., Fatini, C., Mirizzi, G., Poletti, R., Borrelli, C., Prontera, C., Latini, R., Passino, C., Clerico, A., & Vergaro, G. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.10.031 · Cited by 33
The Egyptian Hypertension Society
(2014) · The Egyptian Heart Journal · doi:10.1016/j.ehj.2014.03.001 · Cited by 33
Dong, H., Zou, Y., He, J., Deng, Y., Chen, Y., Song, L., Xu, B., Gao, R., & Jiang, X. (2021) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.29554 · Cited by 33
Ozeki, Y., Tanimura, Y., Nagai, S., Nomura, T., Kinoshita, M., Shibuta, K., Matsuda, N., Miyamoto, S., Yoshida, Y., Okamoto, M., et al. (2021) · Diagnostics · doi:10.3390/diagnostics11030433 · Cited by 32
Park, K. S., Kim, J. H., Ku, E. J., Hong, A. R., Moon, M. K., Choi, S. H., Shin, C. S., Kim, S. W., & Kim, S. Y. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0074 · Cited by 32
Sigurjónsdóttir, H. Á., Gronowitz, M., Andersson, O., Eggertsen, R., Herlitz, H., Sakinis, A., Wängberg, B., & Johannsson, G. (2012) · BMC Endocrine Disorders · doi:10.1186/1472-6823-12-17 · Cited by 32
Glinicki, P., Jeske, W., Papierska, L., Kruszyńska, A., Gietka‐Czernel, M., Rosłonowska, E., Slowinska-Srzednicka, J., Kasperlik-Zaluska, A. A., & Zgliczyński, W. (2014) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320313519487 · Cited by 32
Disordered aldosterone-volume relationship in end-stage kidney disease
Bomback, A. S., Kshirsagar, A., Ferris, M., & Klemmer, P. (2009) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320309352353 · Cited by 28
Bongarzone, S., Basagni, F., Sementa, T., Singh, N., Gakpetor, C., Faugeras, V., Bordoloi, J., & Gee, A. D. (2019) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2018.11.002 · Cited by 31
Endocrine Hypertension: Then and Now
Young, W. F. (2010) · Endocrine Practice · doi:10.4158/ep10205.ra · Cited by 31
Self-citationThe phenotype characteristics of type 13 long QT syndrome with mutation in KCNJ5 (Kir3.4-G387R)
Wang, F., Liu, J., Li, H., Liang, B., Graff, C., Yang, Y., Christiansen, M., Olesen, S., Zhang, L., & Kanters, J. K. (2013) · Heart Rhythm · doi:10.1016/j.hrthm.2013.07.022 · Cited by 31
CT mapping of the vertebral level of right adrenal vein
Degenhart, C., Strube, H., Betz, M. J., Pallauf, A., Bidlingmaier, M., Fischer, E., Reincke, M., Reiser, M. F., & Wirth, S. (2014) · Diagnostic and Interventional Radiology · doi:10.5152/dir.2014.14026 · Cited by 31
Endocrine Hypertension: A Practical Approach
Pappachan, J. M., & Buch, H. (2016) · Advances in experimental medicine and biology · doi:10.1007/5584_2016_26 · Cited by 32
Dinh, Q. N., Vinh, A., Kim, H. A., Saini, N., Broughton, B. R. S., Chrissobolis, S., Diep, H., Judkins, C. P., Drummond, G. R., & Sobey, C. G. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa075 · Cited by 31
Goupil, R., Wolley, M. J., Ungerer, J. P. J., McWhinney, B. C., Mukai, K., Naruse, M., Gordon, R. D., & Stowasser, M. (2015) · Endocrinology Diabetes and Metabolism Case Reports · doi:10.1530/edm-15-0075 · Cited by 31
Self-citationMorita, S., Nishina, Y., Yamazaki, H., Sonoyama, Y., Ichihara, A., & Sakai, S. (2015) · European Radiology · doi:10.1007/s00330-015-4073-9 · Cited by 31
Pathophysiology, Evaluation, and Medical Management of Adrenal Disorders
Kutikov, A., Crispen, P. L., & Uzzo, R. G. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6911-9.00057-8 · Cited by 31
on behalf of the TAIPAI Study Group, Chang, C., Lee, B., Chang, Y., Wu, V., Huang, K., & Liu, K. (2017) · European Radiology · doi:10.1007/s00330-017-4930-9 · Cited by 31
The Endocrine System and the Heart: A Review
Rhee, S. S., & Pearce, E. N. (2011) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2010.10.016 · Cited by 30
Glucose Metabolism in Primary Aldosteronism
Remde, H., Hanslik, G., Rayes, N., & Quinkler, M. O. (2015) · Hormone and Metabolic Research · doi:10.1055/s-0035-1565208 · Cited by 30
Local Control of Aldosterone Production and Primary Aldosteronism
Lalli, E., Barhanin, J., Zennaro, M., & Warth, R. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.01.003 · Cited by 30
Robot‐assisted vs open adrenalectomy: evaluation of cost‐effectiveness and peri‐operative outcome
Probst, K. A., Ohlmann, C., Saar, M., Siemer, S., Stöeckle, M., & Janssen, M. W. W. (2016) · British Journal of Urology · doi:10.1111/bju.13529 · Cited by 30
Wang, L., Li, N., Yao, X., Chang, G., Zhang, D., Heizhati, M., Wang, M., Luo, Q., & Kong, J. (2017) · BioMed Research International · doi:10.1155/2017/8295010 · Cited by 30
Perez‐Rivas, L. G., Williams, T. A., & Reincke, M. (2018) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0713-0629 · Cited by 30
Fischer, E., Beuschlein, F., Degenhart, C., Jung, P., Bidlingmaier, M., & Reincke, M. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04243.x · Cited by 30
Primary aldosteronism: emerging trends
Galati, S.-J., Hopkins, S. M., Cheesman, K. C., Zhuk, R. A., & Levine, A. C. (2013) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2013.05.003 · Cited by 31
Graham, U. M., McCance, D. R., Young, I. S., & Mullan, K. (2013) · Journal of Human Hypertension · doi:10.1038/jhh.2013.89 · Cited by 30
Diagnosis of Diseases of Steroid Hormone Production, Metabolism and Action
Honour, J. W. (2009) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.v1i5.209 · Cited by 30
Worth, P. J., Kunio, N. R., Siegfried, I., Sheppard, B. C., & Gilbert, E. W. (2015) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2015.05.033 · Cited by 30
Carter, Y. M., Roy, M., Sippel, R. S., & Chen, H. (2012) · Journal of Surgical Research · doi:10.1016/j.jss.2012.07.059 · Cited by 30
Post-saline infusion test aldosterone levels indicate severity and outcome in primary aldosteronism
Weigel, M., Riester, A., Hanslik, G., Lang, K., Willenberg, H. S., Endres, S., Allolio, B., Beuschlein, F., Reincke, M., & Quinkler, M. O. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-1013 · Cited by 30
Too Much of a Good Thing: A Woman with Hypertension and Hypokalemia
Murphy, S. C., Agger, S., & Rainey, P. M. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2009.127506 · Cited by 30
Worsening of lipid metabolism after successful treatment of primary aldosteronism
Adolf, C., Asbach, E., Dietz, A., Lang, K., Hahner, S., Quinkler, M. O., Rump, L. C., Bidlingmaier, M., Treitl, M., Ladurner, R., et al. (2016) · Endocrine · doi:10.1007/s12020-016-0983-9 · Cited by 30
Yang, T., Zhang, H., Liang, Q., Shi, Y., Mei, Y., Barrett, P. Q., & Hu, C. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.07094 · Cited by 30
de Souza, F., Muxfeldt, E. S., Margallo, V. S., Cortez, A. F., Cavalcanti, A. H., & Salles, G. F. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001254 · Cited by 30
Willenberg, H. S., Kolentini, C., Quinkler, M. O., Cupisti, K., Krausch, M., Schott, M., & Scherbaum, W. A. (2008) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2008.02060.x · Cited by 30
Mutations of the Potassium Channel KCNJ5 Causing Aldosterone-Producing Adenomas
Gómez-Sánchez, C. E., & Gómez-Sánchez, E. P. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.186205 · Cited by 30
Diagnosis and treatment of primary aldosteronism
Mulatero, P., Monticone, S., & Veglio, F. (2011) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-011-9156-6 · Cited by 29
Adrenal disease: a clinical update and overview of imaging. A review
Čtvrtlík, F., Koranda, P., & Tichý, T. (2014) · Biomedical Papers · doi:10.5507/bp.2014.010 · Cited by 28
Rossi, G. P., Seccia, T. M., Gallina, V., Muiesan, M. L., Leoni, L., Pengo, M. F., Ragazzo, F., Caielli, P., Belfiore, A., BERNINI, G. P., et al. (2012) · Journal of Human Hypertension · doi:10.1038/jhh.2012.21 · Cited by 29
Self-citationEvaluation of primary aldosteronism
Mulatero, P., Monticone, S., Bertello, C., Tizzani, D., Iannaccone, A., Crudo, V. L., & Veglio, F. (2010) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3283390f8d · Cited by 29
Zhang, Y., Niu, W., Zheng, F., Zhang, H., Zhou, W., Shen, Z., Xu, J., Tang, X., Zhang, J., Gao, P., et al. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001488 · Cited by 29
Therapeutic Outcomes with Surgical and Medical Management of Primary Aldosteronism
Wachtel, H., & Fraker, D. L. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01516-0 · Cited by 29
Ahmed, A. H., Gordon, R. D., Ward, G., Wolley, M. J., Kogovsek, C., & Stowasser, M. (2014) · Clinical Endocrinology · doi:10.1111/cen.12705 · Cited by 29
Self-citationWu, C., Yang, Y., Hu, Y., Tsai, Y., Kuo, K.-L., Lin, Y., Hung, S., Wu, V., Wu, K., & the Taiwan Primary Aldosteronism Investigation (TAIPAI) Study Group (2013) · PLoS ONE · doi:10.1371/journal.pone.0067417 · Cited by 29
Successful Adrenal Venous Sampling by Non-experts with Reference to CT Images
Morita, S., Yamazaki, H., Sonoyama, Y., Nishina, Y., Ichihara, A., & Sakai, S. (2016) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-016-1335-0 · Cited by 29
Peripheral Arterial Stiffness in Primary Aldosteronism
Rosa, J., Šomlóová, Z., Petrák, O., Štrauch, B., Indra, T., Šenitko, M., Zelinka, T., Holaj, R., & Widimsky, J., Jr. (2012) · Physiological Research · doi:10.33549/physiolres.932344 · Cited by 31
A Novel Method of Adrenal Venous Sampling via an Antecubital Approach
Jiang, X., Dong, H., Peng, M., Che, W., Zou, Y., Song, L., Zhang, H., & Wu, H. (2016) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-016-1524-x · Cited by 29
Citton, M., Viel, G., Torresan, F., Rossi, G. P., & Iacobone, M. (2019) · BMC Surgery · doi:10.1186/s12893-018-0432-1 · Cited by 28
Success rate of adrenal venous sampling and predictors for success: a retrospective study
Chayovan, T., Limumpornpetch, P., & Hongsakul, K. (2019) · Polish Journal of Radiology · doi:10.5114/pjr.2019.84178 · Cited by 28
Park, S. I., Rhee, Y., Lim, J. S., Park, S., Kang, S., Lee, M. S., Lee, M., Lee, S. J., Kim, I. J., Lee, D. Y., et al. (2013) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-013-0820-y · Cited by 27
Spyroglou, A., Bozoglu, T. M., Rawal, R., Leonardis, F. D., Sterner, C. W., Boulkroun, S., Benecke, A., Monti, L., Zennaro, M., Petersen, A.-K., et al. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.02504 · Cited by 28
Berardelli, R., Karamouzis, I., Marinazzo, E., Prats, E., Picu, A., Giordano, R., Ghigo, E., & Arvat, E. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-1076 · Cited by 28
Physiologic variance of corticotropin affects diagnosis in adrenal vein sampling
Tanemoto, M., Suzuki, T., Abe, M., Abe, T., & Ito, S. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0840 · Cited by 28
Morimoto, R., Satani, N., Iwakura, Y., Ono, Y., Kudo, M., Nezu, M., Omata, K., Tezuka, Y., Seiji, K., Ota, H., et al. (2015) · Journal of Human Hypertension · doi:10.1038/jhh.2015.100 · Cited by 28
Ioachimescu, A. G., Remer, E. M., & Hamrahian, A. H. (2015) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.02.005 · Cited by 28
Kaplan, N. M. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283559a03 · Cited by 27
Tsiavos, V., Markou, Α., Papanastasiou, L., Kounadi, T., Androulakis, I. I., Voulgaris, N., Zachaki, A., Kassi, E. N., Kaltsas, G., Chrousos, G. P., et al. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0003 · Cited by 27
Lee, J., Kang, B., Ha, J., Kim, M., Choi, B., Hong, T. H., Kang, M. I., & Lim, D. (2020) · BMC Endocrine Disorders · doi:10.1186/s12902-020-00591-8 · Cited by 29
Jing, Y., Liao, K., Li, R., Yang, S., Song, Y., He, W., Wang, K., Yang, J., Li, Q., & Hu, J. (2021) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/14703203211003781 · Cited by 27
Robles‐Vera, I., de la Visitación, N., Toral, M., Sánchez, M., Romero, M., Gómez‐Guzmán, M., Vargas, F., Duarte, J., & Jiménez, R. (2021) · Nutrients · doi:10.3390/nu13092971 · Cited by 27
FDG PET/CT Scan and Functional Adrenal Tumors: A Pilot Study for Lateralization
Patel, D., Gara, S. K., Ellis, R. J., Boufraqech, M., Nilubol, N., Millo, C., Stratakis, C. A., & Kebebew, E. (2015) · World Journal of Surgery · doi:10.1007/s00268-015-3242-y · Cited by 28
Pilz, S., Tomaschitz, A., Stepan, V. M., Obermayer-Pietsch, B. M., Fahrleitner‐Pammer, A., Schweighofer, N., Portugaller, H. R., Sourij, H., Dobnig, H., Meinitzer, A., et al. (2009) · BMC Endocrine Disorders · doi:10.1186/1472-6823-9-11 · Cited by 26
Familial or Genetic Primary Aldosteronism and Gordon Syndrome
Stowasser, M., Pimenta, E., & Gordon, R. D. (2011) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2011.01.007 · Cited by 26
Self-citationCaptopril suppression: limitations for confirmation of primary aldosteronism
Westerdahl, C., Bergenfelz, A. O. J., Isaksson, A., & Valdemarsson, S. V. (2011) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320310390405 · Cited by 27
Metadata
- Authors
- Funder, J. W., Carey, R. M., Fardella, C., Gomez-Sanchez, C. E., Mantero, F., Stowasser, M., Young, W. F., & Montori, V. M.
- Affiliations
- Prince Henry’s Institute of Medical Research (J.W.F.), Clayton VIC 3168, Australia
- University of Virginia Health System (US)
- Pontificia Universidad Católica de Chile (CL)
- G.V. (Sonny) Montgomery VA Medical Center (C.E.G.-S.), Jackson, Mississippi 39216
- University of Padua (IT)
- The University of Queensland (AU)
- Mayo Clinic (US)
- Mayo Clinic (W.F.Y., V.M.M.), Rochester, Minnesota 55902
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2008-09-01
- Volume
- 93
- Issue
- 9
- Pages
- 3266-3281
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2156903075
- Cited by
- 1,554
- References
- 145
- Citations by year
- 2026: 19 · 2025: 29 · 2024: 34 · 2023: 42 · 2022: 42 · 2021: 51 · 2020: 50 · 2019: 56 · 2018: 70 · 2017: 84 · 2016: 158 · 2015: 182 · 2014: 135 · 2013: 127 · 2012: 169
- FWCI
- 72.82
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Americanae (AECID Library) (submittedVersion, other-oa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Keywords
- primary aldosteronism, case finding, aldosterone-renin ratio, confirmatory testing, adrenal computed tomography, unilateral primary aldosteronism, laparoscopic adrenalectomy, bilateral adrenal hyperplasia, mineralocorticoid receptor antagonists, hypertension, hypokalemia
- MeSH terms
- Eplerenone, Mineralocorticoid Receptor Antagonists, Algorithms, Catheterization, Combined Modality Therapy, Cosyntropin, Diagnostic Techniques, Endocrine, Humans, Hyperaldosteronism, Spironolactone, Reproducibility of Results, Hormone Replacement Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review